ALEKSANDR VYDRO: Open Payments
NPI 1124130430 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,017 in 29 payments from 6 companies in 2025. Trend: 2023 $660 · 2024 $764 · 2025 $1,017
Food & beverage: $1,017
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 9 | $363 |
| Janssen Pharmaceuticals, Inc | 6 | $175 |
| Vanda Pharmaceuticals Inc. | 6 | $159 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 4 | $114 |
| ABBVIE INC. | 3 | $81 |
Products named: ARISTADA, INVEGA SUSTENNA, FANAPT, COBENFY, LYBALVI, ABILIFY MAINTENA, VRAYLAR, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
